Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02266797 · ClinicalTrials.gov registry record · Phase 3
Effect of Intravenous Corticosteroid Injections on Dysphagia After Cervical Spine Surgery
A Phase 3 study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- Phase 3
- Development phase
- 4
- Enrollment target
NCT02266797 is a Phase 3 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 4 participants.
The verdict
NCT02266797, a Phase 3 study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled study to examine the effect of local intravenous steroids following anterior cervical spine surgery on the development of dysphagia in patients.
Interventions
- OTHER Saline
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-09-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02266797
The ClinicalTrials.gov registry entry for NCT02266797 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02266797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02266797 about?
NCT02266797 is a clinical study titled "Effect of Intravenous Corticosteroid Injections on Dysphagia After Cervical Spine Surgery". This is a randomized, double-blind, placebo-controlled study to examine the effect of local intravenous steroids following anterior cervical spine surgery on the development of dysphagia in patients.
What is the current status of trial NCT02266797?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 4 participants. The study started on 2013-11. Estimated completion is 2015-09-01.
What interventions are being tested in trial NCT02266797?
The interventions under investigation include: Saline (OTHER), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT02266797?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.